<DOC>
	<DOCNO>NCT00866203</DOCNO>
	<brief_summary>The study plan compare outcome aggressive NHL patient partial remission four course front-line therapy , randomly assign receive either additional four course regimen modify HDS program .</brief_summary>
	<brief_title>HDS Plus PBPC Transplant Vs 4 More Courses FrontLine Therapy Pts With Aggressive NHL PR After Induction Therapy</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<criteria>Newly diagnose , untreated patient histologically document aggressive lymphoma ; Age 18 65 year ; Clinical stage diagnosis : I A bulky IV B ; Reduction tumoral mass , four course induction therapy , 50 75 % ; Serum negativity HIV , HbsAg HCV ; ECOG performance status 0 4 ; Adequate bone marrow function ; Adequate renal hepatic function ; Left ventricular ejection fraction ( LVEF ) &gt; 50 % ; No previous malignant disease ; No previous chemoradiotherapy ; No cerebral CNS involvement , assess clinical history , physical examination CSF examination lumbar puncture ; Written inform consent give time randomization . Clinical stage I bulky , CS IIAB less three site disease involve ; Patients CR , unconfirmed complete remission ( uCR ) , good PR ( &gt; 75 % ) clinical response le 50 % , define Cheson et al. , follow four course induction therapy ; Tumor involvement CNS ( except patient peridural mass without liquor involvement , enrol study ) ; Indolent lymphoma transform aggressive histologic type , even never previously treat ; Aggressive nonHodgkin 's lymphoma pretransplanted patient ; Clinically significant secondary cardiovascular disease e.g . uncontrolled hypertension , ( rest diastolic blood pressure &gt; 115 mmHg ) , uncontrolled multifocal cardiac arrhythmia , symptomatic angina pectoris congestive cardiac failure NYHA class IIIIV ; Left ventricular ejection fraction ( LVEF ) &lt; 50 % ; Evidence severe active acute chronic infection ; Concurrent malignancy history malignancy , except basal cell carcinoma skin ( BCC ) situ cervical carcinoma ( CIN ) ; myelodisplastic syndrome ; HbsAg , HIVpositive , HCVRNApositive patient ; Patient psychiatric , disorder compromise ability give truly informed consent participation study ; Pregnant woman ; potential childbearing woman enrol adequate contraceptive precaution use enter trial duration trial ; Concerns patient 's compliance protocol procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>